Roche gave an update this week about GENERATION HD2, testing the HTT-lowering drug tominersen in people with HD. The trial is ...

A recent paper links CAG repeat expansion with widespread RNA changes, especially in brain cells vulnerable to HD. “Knocking ...

New research shines a light on an often-overlooked side of Huntington’s disease—psychosis. Understanding the impact of ...

New research suggests the adult brain can be convinced to grow new neurons to replace those lost in Huntington’s disease. The ...

In plain language. Written by scientists. For the global HD community.

Michael is a consultant neurologist in the department of neurology at the University of Ulm in Germany, and scientific projects manager for the European Huntington’s disease network. Michael trained ...